REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $385,122 | +34.2% | 2,422 | +57.8% | 0.01% | +20.0% |
| Q3 2022 | $287,000 | +8.7% | 1,535 | +54.0% | 0.01% | 0.0% |
| Q4 2021 | $264,000 | -11.4% | 997 | -3.1% | 0.01% | -16.7% |
| Q3 2021 | $298,000 | +106.9% | 1,029 | +42.3% | 0.01% | +100.0% |
| Q2 2021 | $144,000 | +42.6% | 723 | +38.8% | 0.00% | +50.0% |
| Q1 2021 | $101,000 | -1.0% | 521 | -1.9% | 0.00% | -33.3% |
| Q4 2020 | $102,000 | +1357.1% | 531 | +1080.0% | 0.00% | – |
| Q3 2020 | $7,000 | -99.1% | 45 | -99.3% | 0.00% | -100.0% |
| Q2 2020 | $812,000 | +23.4% | 6,562 | -3.4% | 0.02% | +8.7% |
| Q1 2020 | $658,000 | -46.9% | 6,791 | -49.4% | 0.02% | -17.9% |
| Q4 2019 | $1,239,000 | +9.3% | 13,414 | -9.3% | 0.03% | +3.7% |
| Q3 2019 | $1,134,000 | +88.4% | 14,791 | +110.5% | 0.03% | +92.9% |
| Q2 2019 | $602,000 | +45.8% | 7,025 | 0.0% | 0.01% | +40.0% |
| Q1 2019 | $413,000 | – | 7,025 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |